Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NCT07071246
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Treatment
Interventions
DRUG:
Rituximab Injection
Sponsor
Tang-Du Hospital